Gates Capital Management’s Labcorp LH Stock Holding History

Gates Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-632,901	Closed	-$131M	–	33
2023 Q2	$131M	Buy	+632,901	New	+$123M	3.09%	14

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gates Capital Management's LH Position: Q3 2023 in Review

Gates Capital Management sold out of Labcorp (LH) in Q3 2023, closing a stake of 632,901 shares — an estimated $131M sold.

Gates Capital Management first reported a position in LH in Q2 2023 and held it in 1 quarter. The position peaked at $131M in Q2 2023. 881 funds tracked by Wall St. Rank hold LH as of Q3 2023.

Gates Capital Management reported no remaining Labcorp position as of Q3 2023 after selling out during the quarter.
Gates Capital Management sold 632,901 Labcorp shares in Q3 2023, an estimated $131M.
Gates Capital Management first reported a position in Labcorp in Q2 2023 and held it in 1 quarter.
Gates Capital Management's Labcorp position peaked at $131M in Q2 2023.
881 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.

Based on Gates Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.